United States · FDA National Drug Code directory
Venlafaxine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82009-057_b5d4c4fe-1c29-466a-9ca6-6267c7a954eb
- Product NDC
- 82009-057
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Venlafaxine Hydrochloride
- Labeler
- QUALLENT PHARMACEUTICALS HEALTH LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221121
- Source listing expiry
- 20261231
Source-listed ingredients
- VENLAFAXINE HYDROCHLORIDE — 75 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (82009-057-10) · 82009-057-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →